IMMUNOTHERAPY FOR PROSTATIC CANCER - PREVIOUS AND PROSPECTIVE CONSIDERATIONS

被引：20

作者：

ABLIN, RJ

机构：

[1] COOK CTY HOSP, DIV IMMUNOL, IMMUNOBIOL SECT, CHICAGO, IL 60612 USA

[2] COOK CTY HOSP, CTR STUDY PROSTATIC DIS, DEPT SURG, DIV UROL, CHICAGO, IL 60612 USA

[3] HEKTOEN INST MED RES, GRAD SCH MED, CHICAGO, IL 60600 USA

[4] UNIV HLTH SCI, MED SCH, DEPT MICROBIOL, CHICAGO, IL 60612 USA

来源：

关键词：

D O I：

10.1159/000225023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：177 / 202

页数：26

共 138 条

[11]

ABLIN RJ, 1969, EXP MED SURG, V27, P406

[12]

ABLIN RJ, 1970, J REPROD FERTIL, V22, P573

[13]

ABLIN RJ, 1971, J IMMUNOL, V107, P603

[14]

ABLIN RJ, 1972, CANCER-AM CANCER SOC, V29, P1570, DOI 10.1002/1097-0142(197206)29:6<1570::AID-CNCR2820290621>3.0.CO

[15]

2-V

[16]

ABLIN RJ, 1975, CLIN RES, V23, pA286

[17]

ABLIN RJ, 1972, LANCET, V2, P874

[18]

ABLIN RJ, 1973, ISRAEL J MED SCI, V9, P480

[19]

ABLIN RJ, 1974, J IMMUNOL, V113, P705

[20]

ABLIN RJ, 1972, Z IMMUNITATSFORSCH, V142, P432